Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Fu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Therapeutics|November 19, 2023
Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims AnalysisDiane Ito, Chaoling Feng, Christine Fu, et al.
Transplantation and Cellular Therapy|May 2, 2024
Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment CentersNausheen Ahmed, Fang Sun, Christie Teigland, et al.
The Journal of Urology|April 28, 2015
Circulating Tumor Cells as Potential Biomarkers in Bladder CancerAjjai Alva, Terence Friedlander, Melanie Clark, et al.
Annals of Internal Medicine|October 27, 2025
Perspectives on Racial and Ethnic Health Equity in Systematic Reviews and Evidence-Based GuidelinesMeera Viswanathan, Jennifer S Lin, Rania Ali, et al.
Psychology, Health & Medicine|December 23, 2015
Prevalence of depressive symptoms and its correlates among medical students in China: a national survey in 33 universitiesXiong-Fei Pan, Ying Wen, Yun Zhao, et al.
Blood Advances|January 30, 2025
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucelFrederick L Locke, Tanya Siddiqi, Caron A Jacobson, et al.
American Journal of Hematology|March 20, 2024
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapyMatthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Therapeutics|November 19, 2023
Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims AnalysisDiane Ito, Chaoling Feng, Christine Fu, et al.
Transplantation and Cellular Therapy|May 2, 2024
Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment CentersNausheen Ahmed, Fang Sun, Christie Teigland, et al.
The Journal of Urology|April 28, 2015
Circulating Tumor Cells as Potential Biomarkers in Bladder CancerAjjai Alva, Terence Friedlander, Melanie Clark, et al.
Annals of Internal Medicine|October 27, 2025
Perspectives on Racial and Ethnic Health Equity in Systematic Reviews and Evidence-Based GuidelinesMeera Viswanathan, Jennifer S Lin, Rania Ali, et al.
Psychology, Health & Medicine|December 23, 2015
Prevalence of depressive symptoms and its correlates among medical students in China: a national survey in 33 universitiesXiong-Fei Pan, Ying Wen, Yun Zhao, et al.
Blood Advances|January 30, 2025
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucelFrederick L Locke, Tanya Siddiqi, Caron A Jacobson, et al.
American Journal of Hematology|March 20, 2024
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapyMatthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, et al.
Pageof 2